Cryopreservation extends the viability of cells by cooling them to extremely low temperatures and thus keeping them in a safe, biochemically inactive state. This process gives much-needed flexibility to researchers and those developing cell-based therapies. The latter involves collecting living cells from donors, transporting them to manufacturing sites for processing or screening, and then delivering […]
View Blog
When Pfizer initially released its COVID-19 mRNA vaccine, distributing it was a major challenge. Scientists thought that the vaccine had to be stored at -70°C, requiring dry ice or ultra-cold freezers. At scale, explains David Lewandowski, Azenta’s Strategic Partnerships Manager for Automated Storage, “Temperature matters. The warmer it is, the easier it is [to deliver […]
View Blog
Part 3 of our A Practical Guide to Planning a Cryogenic Storage Facility Series In our previous blog post, we uncovered key safety considerations and why monitoring your LN2 facility and storage units is imperative in ensuring the safety of your facility. In this part of our blog series, we lay out the key factors to […]
View Blog
Part 2 of our Protecting Complete Chain of Custody Series As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs. Like any part of a controlled process, establishment of a quality […]
View Blog
Part 2 of our A Practical Guide to Planning a Cryogenic Storage Facility Series In our previous post, we covered several key considerations for selecting the appropriate space and equipment when designing your cryogenic storage facility. In this post, we will highlight how to ensure the safety of your facility. Did you know that a proper […]
View Blog
Part 1 of our Protecting Complete Chain of Custody Series As key components of the research ecosystem, biobanks share a vital function and critical responsibility in the protection of biospecimens. They are centralized members in the chain of custody for samples, and as such, have an impact on both upstream and downstream portions of the molecular biologist’s […]
View Blog
Part 1 of our A Practical Guide to Planning a Cryogenic Storage Facility Series Storing biological materials, especially living cells and tissues, can be a complicated process. Improper handling or storage conditions can damage cells, reducing viability and compromising their utility in downstream applications. Keeping specimens below -135°C, the glass transition temperature (Tg) of water, […]
View Blog
Manufacturing and distribution of advanced therapies relies on stable low temperatures. Cellular products and other biological materials are often stored below -135°C, the glass transition temperature of water (Tg), where enzymatic activity is believed to cease. Routine handling in and out of storage can expose materials to temperatures above Tg, leading to degradation and reduced […]
View Blog
As cell and gene therapies (CGT) advance into the clinical stage, many cold chain complexities arise not only for these novel products but also for the biological samples that must be collected from patients during clinical trials. Managing these sensitive materials—including storage, transportation, and tracking—requires robust and adaptable systems to ensure safety, integrity, and regulatory […]
View Blog
Vaccines are some of the most valuable biological materials that clinicians produce and use. They help prevent health issues for millions each year. However, much of the vaccines lost are due to degradation that occurs when they warm during vaccine transport. Extreme weather, natural disasters, and other emergencies can put laboratories at risk and can […]
View Blog